AVROBIO, Inc.

• CAMBRIDGE, MA How do I update this listing?

Avrobio is based out of Cambridge. Avrobio, Inc. operates as a bio-technology company. The Company develops step-change cell and gene therapies for the treatment of cancer and rare disease. Avrobio serves clients in the United States and Canada. The firm last filed a Form D notice of exempt offering of securities on 2018-02-02. The notice included securities offered of Equity

Create Alert

Contact Info

avrobio, inc.
ONE KENDALL SQUARE
CAMBRIDGE MA    02139
Business Phone: 7819626030
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-02-02 D BIOTECHNOLOGY Equity 60,999,978 60,499,978 500,000
2016-08-03 D BIOTECHNOLOGY Equity 25,000,000 7,500,000 17,500,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
BRUCE BOOTH subscription required
    DIRECTOR
CHRISTOPHER MASON subscription required
    EXECUTIVE OFFICER
CHRISTOPHER PAIGE subscription required
    DIRECTOR
DEANNA PETERSEN subscription required
    EXECUTIVE OFFICER
GEOFFREY MACKAY subscription required
    EXECUTIVE OFFICER DIRECTOR
IAN CLARK subscription required
    DIRECTOR
JOSHUA RESNICK subscription required
    DIRECTOR
KATINA DORTON subscription required
    EXECUTIVE OFFICER
KIM WARREN subscription required
    EXECUTIVE OFFICER
SCOTT REQUADT subscription required
    DIRECTOR

Elevate your investments